We had a wonderful time hosting Professor Ivan Dikic at @ucberkeleyofficial.bsky.social.
A pioneer in ubiquitin biology, his work defined ubiquitin signaling as a key entry point for therapeutic innovation.
Excited to see growing collaboration with PROXIDRUGS.
#MolecularTherapeutics
